Replies to post #231366 on NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

rogers5729,

Look at slide 33: https://nwbio.com/wp-content/uploads/ASCO-2019-Presentation-FINAL.pdf

7 patients lived for 3 years or more.
3 patients died between 35 and 36 months.

7/25= 28%

IMO 28% (from the Information Arm) appear consistent with the blinded interim data from the trial.

SNO data 2018:
Survival of the whole ITT population at 3 years: 28.2%

Marnix Bosch min.1.50s